{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:06:01Z","timestamp":1778864761741,"version":"3.51.4"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vascn.2022.107157","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T23:52:45Z","timestamp":1644277965000},"page":"107157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["High-content analysis and Kinetic Image Cytometry identify toxicity and epigenetic effects of HIV antiretrovirals on human iPSC-neurons and primary neural precursor cells"],"prefix":"10.1016","volume":"114","author":[{"given":"Alyson S.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soneela","family":"Ankam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Farhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Fiengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranor C.B.","family":"Basa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara L.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey V.","family":"Terskikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly L.","family":"Jordan-Sciutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"McDonough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2022.107157_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13365-013-0227-1","article-title":"Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system","volume":"20","author":"Akay","year":"2014","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/j.vascn.2022.107157_bb0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.expneurol.2016.01.020","article-title":"In vitro models of axon regeneration","volume":"287","author":"Al-Ali","year":"2017","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.aat0473","article-title":"Glia as architects of central nervous system formation and function","volume":"362","author":"Allen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.vascn.2022.107157_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00466-19","article-title":"Novel Central Nervous System (CNS)-targeting protease inhibitors for drug-resistant HIV infection and HIV-associated CNS complications","volume":"63","author":"Amano","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.vascn.2022.107157_bb0025","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies","volume":"4","author":"Antiretroviral Therapy Cohort, C","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.vascn.2022.107157_bb0030","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/jac\/dkv183","article-title":"Efavirenz and the CNS: What we already know and questions that need to be answered","volume":"70","author":"Apostolova","year":"2015","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.vascn.2022.107157_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207005","article-title":"Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020","volume":"13","author":"Autenrieth","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2022.107157_bb0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2022.107157_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ntt.2008.12.003","article-title":"Relevance of in vitro neurotoxicity testing for regulatory requirements: Challenges to be considered","volume":"32","author":"Bal-Price","year":"2010","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1016\/j.vascn.2022.107157_bb0050","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/jac\/dkz217","article-title":"Population pharmacokinetics of dolutegravir: Influence of drug-drug interactions in a real-life setting","volume":"74","author":"Barcelo","year":"2019","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.vascn.2022.107157_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1212\/WNL.0000000000000580","article-title":"The relationship of CPE to HIV dementia: Slain by an ugly fact?","volume":"83","author":"Berger","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00441-014-1798-8","article-title":"Network-wide dysregulation of calcium homeostasis in Alzheimer\u2019s disease","volume":"357","author":"Brawek","year":"2014","journal-title":"Cell and Tissue Research"},{"key":"10.1016\/j.vascn.2022.107157_bb0065","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1086\/650744","article-title":"Benefit or toxicity from neurologically targeted antiretroviral therapy?","volume":"50","author":"Brew","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vascn.2022.107157_bb0070","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00018-013-1550-7","article-title":"Neuronal calcium signaling: Function and dysfunction","volume":"71","author":"Brini","year":"2014","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.vascn.2022.107157_bb0075","article-title":"Efavirenz promotes beta-secretase expression and increased Abeta1-40,42 via oxidative stress and reduced microglial phagocytosis: Implications for HIV associated neurocognitive disorders (HAND)","volume":"9","author":"Brown","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2022.107157_bb0080","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1158\/1535-7163.MCT-09-1148","article-title":"High-content phenotypic profiling of drug response signatures across distinct cancer cells","volume":"9","author":"Caie","year":"2010","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.vascn.2022.107157_bb0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000000564","article-title":"Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions","volume":"83","author":"Caniglia","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0090","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/QAD.0000000000002300","article-title":"Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications","volume":"33","author":"Chaganti","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.vascn.2022.107157_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11481-007-9092-0","article-title":"Antiretroviral treatment is associated with increased attentional load-dependent brain activation in HIV patients","volume":"3","author":"Chang","year":"2008","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.vascn.2022.107157_bb0100","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vascn.2022.107157_bb0105","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0110","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2022.107157_bb0115","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/cid\/ciu1144","article-title":"Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls","volume":"60","author":"Cohen","year":"2015","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vascn.2022.107157_bb0125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/rmv.1793","article-title":"Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy","volume":"24","author":"Crowell","year":"2014","journal-title":"Reviews in Medical Virology"},{"key":"10.1016\/j.vascn.2022.107157_bb0130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts","volume":"10","author":"Cysique","year":"2004","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/j.vascn.2022.107157_bb0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-med-092112-152941","article-title":"Understanding HIV latency: the road to an HIV cure","volume":"66","author":"Dahabieh","year":"2015","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.vascn.2022.107157_bb0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.10827","article-title":"Changing incidence of central nervous system diseases in the EuroSIDA cohort","volume":"55","author":"d\u2019Arminio Monforte","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/QAI.0000000000002338","article-title":"Mother-to-child HIV transmission with in utero Dolutegravir vs. Efavirenz in Botswana","volume":"84","author":"Davey","year":"2020","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.vascn.2022.107157_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnins.2015.00093","article-title":"Neurotoxic effects of AZT on developing and adult neurogenesis","volume":"9","author":"Demir","year":"2015","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.vascn.2022.107157_bb0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/dky384","article-title":"Pharmacokinetics of dolutegravir with and without darunavir\/cobicistat in healthy volunteers","volume":"74","author":"Elliot","year":"2019","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.vascn.2022.107157_bb0160","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49683","article-title":"Improving drug discovery using image-based multiparametric analysis of the epigenetic landscape","volume":"8","author":"Farhy","year":"2019","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.vascn.2022.107157_bb0165","first-page":"7","article-title":"Attacking AIDS with a \u201cCocktail\u201d therapy: Drug combo sends deaths plummeting","volume":"33","author":"FDA","year":"1999","journal-title":"In HIV\/AIDS News."},{"key":"10.1016\/j.vascn.2022.107157_bb0170","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/QAD.0000000000002628","article-title":"Antiretroviral drug concentrations in brain tissue of adult decedents","volume":"34","author":"Ferrara","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.vascn.2022.107157_bb0175","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/QAD.0000000000002506","article-title":"Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy","volume":"34","author":"Fields","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.vascn.2022.107157_bb0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0959-4388(02)00327-6","article-title":"Molecular mechanisms of CaMKII activation in neuronal plasticity","volume":"12","author":"Fink","year":"2002","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/j.vascn.2022.107157_bb0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/009286150103500134","article-title":"Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical Markets-1960 to 1999","volume":"35","author":"Fung","year":"2001","journal-title":"Drug Information Journal: DIJ \/ Drug Information Association"},{"key":"10.1016\/j.vascn.2022.107157_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajpath.2016.09.006","article-title":"HIV protease inhibitors Alter amyloid precursor protein processing via beta-site amyloid precursor protein cleaving enzyme-1 translational up-regulation","volume":"187","author":"Gannon","year":"2017","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.vascn.2022.107157_bb0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1756-6606-4-23","article-title":"Antiretroviral medications disrupt microglial phagocytosis of beta-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders","volume":"4","author":"Giunta","year":"2011","journal-title":"Molecular Brain"},{"key":"10.1016\/j.vascn.2022.107157_bb0205","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/s41598-020-60684-1","article-title":"Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages","volume":"10","author":"Gong","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2022.107157_bb0210","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11065-009-9095-0","article-title":"Functional consequences of HIV-associated neuropsychological impairment","volume":"19","author":"Gorman","year":"2009","journal-title":"Neuropsychology Review"},{"key":"10.1016\/j.vascn.2022.107157_bb0215","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3389\/fnins.2018.00590","article-title":"In vitro models for seizure-liability testing using induced pluripotent stem cells","volume":"12","author":"Grainger","year":"2018","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.vascn.2022.107157_bb0220","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","article-title":"Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline","volume":"82","author":"Grant","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0225","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2022.107157_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2016.03.019","article-title":"Methylome-wide analysis of chronic HIV infection reveals five-year increase in biological age and epigenetic targeting of HLA","volume":"62","author":"Gross","year":"2016","journal-title":"Molecular Cell"},{"key":"10.1016\/j.vascn.2022.107157_bb0235","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/QAI.0000000000001876","article-title":"Objective and subjective improvement of cognition after discontinuing Efavirenz in asymptomatic patients: A randomized controlled trial","volume":"80","author":"Hakkers","year":"2019","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.vascn.2022.107157_bb0240","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2105-8-110","article-title":"Fast automated cell phenotype image classification","volume":"8","author":"Hamilton","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vascn.2022.107157_bb0245","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1109\/TSMC.1973.4309314","article-title":"Textural features for image classification","volume":"SMC-3","author":"Haralick","year":"1973","journal-title":"IEEE Transactions on Systems, Man, and Cybernetics"},{"key":"10.1016\/j.vascn.2022.107157_bb0250","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0255","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu862","article-title":"Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study","volume":"60","author":"Heaton","year":"2015","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.vascn.2022.107157_bb0260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00006842-199401000-00001","article-title":"Neuropsychological impairment in human immunodeficiency virus-infection: Implications for employment. HNRC group. HIV Neurobehavioral Research Center","volume":"56","author":"Heaton","year":"1994","journal-title":"Psychosomatic Medicine"},{"key":"10.1016\/j.vascn.2022.107157_bb0265","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fnins.2016.00178","article-title":"Alzheimer\u2019s disease and hippocampal adult neurogenesis; Exploring Shared Mechanisms","volume":"10","author":"Hollands","year":"2016","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.vascn.2022.107157_bb0270","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1089\/scd.2014.0531","article-title":"Induced pluripotent stem cell models to enable in vitro models for screening in the central nervous system","volume":"24","author":"Hunsberger","year":"2015","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.vascn.2022.107157_bb0275","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1586\/14787210.2015.999667","article-title":"Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis","volume":"13","author":"Hurst","year":"2015","journal-title":"Expert Review of Anti-Infective Therapy"},{"key":"10.1016\/j.vascn.2022.107157_bb0280","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/NEN.0000000000000255","article-title":"Altered oligodendrocyte maturation and myelin maintenance: The role of antiretrovirals in HIV-associated Neurocognitive disorders","volume":"74","author":"Jensen","year":"2015","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0285","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s13365-011-0032-7","article-title":"Clinical factors related to brain structure in HIV: the CHARTER study","volume":"17","author":"Jernigan","year":"2011","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/j.vascn.2022.107157_bb0290","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1468-1293.2012.01052.x","article-title":"Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score","volume":"14","author":"Kahouadji","year":"2013","journal-title":"HIV Medicine"},{"key":"10.1016\/j.vascn.2022.107157_bb0295","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.2741\/2860","article-title":"HIV\u2019s double strike at the brain: Neuronal toxicity and compromised neurogenesis","volume":"13","author":"Kaul","year":"2008","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.vascn.2022.107157_bb0300","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/QAD.0000000000002377","article-title":"Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances","volume":"34","author":"Lapadula","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.vascn.2022.107157_bb0305","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.vascn.2022.107157_bb0310","first-page":"137","article-title":"Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder","volume":"19","author":"Letendre","year":"2011","journal-title":"Topics in Antiviral Medicine"},{"key":"10.1016\/j.vascn.2022.107157_bb0315","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10974-004-6060-7","article-title":"Specificity of blebbistatin, an inhibitor of myosin II","volume":"25","author":"Limouze","year":"2004","journal-title":"Journal of Muscle Research and Cell Motility"},{"key":"10.1016\/j.vascn.2022.107157_bb0320","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nmeth1032","article-title":"Image-based multivariate profiling of drug responses from single cells","volume":"4","author":"Loo","year":"2007","journal-title":"Nature Methods"},{"key":"10.1016\/j.vascn.2022.107157_bb0325","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":"Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance","volume":"23","author":"Marra","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.vascn.2022.107157_bb0330","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40262-014-0185-7","article-title":"Protecting the fetus against HIV infection: A systematic review of placental transfer of antiretrovirals","volume":"53","author":"McCormack","year":"2014","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.vascn.2022.107157_bb0335","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/adt.2017.797","article-title":"Assay of calcium transients and synapses in rat hippocampal neurons by kinetic image cytometry and high-content analysis: An in vitro model system for postchemotherapy cognitive impairment","volume":"15","author":"McDonough","year":"2017","journal-title":"Assay and Drug Development Technologies"},{"key":"10.1016\/j.vascn.2022.107157_bb0340","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s11064-019-02806-4","article-title":"Characterization of functional primary cilia in human induced pluripotent stem cell-derived neurons","volume":"44","author":"Miki","year":"2019","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.vascn.2022.107157_bb0345","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.329.5991.502","article-title":"Is pharma running out of brainy ideas?","volume":"329","author":"Miller","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.vascn.2022.107157_bb0350","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/QAD.0b013e32834a1dd9","article-title":"Antiviral activity, safety, and pharmacokinetics\/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults","volume":"25","author":"Min","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.vascn.2022.107157_bb0355","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1128\/AAC.00842-09","article-title":"Pharmacokinetics and safety of S\/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers","volume":"54","author":"Min","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.vascn.2022.107157_bb0360","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cei.12814","article-title":"Ageing and inflammation in patients with HIV infection","volume":"187","author":"Nasi","year":"2017","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.vascn.2022.107157_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/biom8030093","article-title":"The biology of glial cells and their complex roles in Alzheimer\u2019s disease: New opportunities in therapy","volume":"8","author":"Nirzhor","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.vascn.2022.107157_bb0370","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuron.2014.10.007","article-title":"Improving and accelerating drug development for nervous system disorders","volume":"84","author":"Pankevich","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.vascn.2022.107157_bb0375","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2015.07.048","article-title":"Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes","volume":"1638","author":"Pei","year":"2016","journal-title":"Brain Research"},{"key":"10.1016\/j.vascn.2022.107157_bb0380","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.vascn.2016.04.007","article-title":"Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes","volume":"81","author":"Pfeiffer","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2022.107157_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106612","article-title":"Electrophysiological characterization of drug response in hSC-derived cardiomyocytes using voltage-sensitive optical platforms","volume":"99","author":"Pfeiffer-Kaushik","year":"2019","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2022.107157_bb0390","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","article-title":"Antiretroviral neurotoxicity","volume":"18","author":"Robertson","year":"2012","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/j.vascn.2022.107157_bb0395","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","article-title":"Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort","volume":"74","author":"Robertson","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0400","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of HIV transmission in Serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.vascn.2022.107157_bb0405","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004259","article-title":"Calcium signaling in neuronal development","volume":"3","author":"Rosenberg","year":"2011","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.vascn.2022.107157_bb0410","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.stemcr.2020.04.006","article-title":"Neuroinflammation and EIF2 signaling persist despite antiretroviral treatment in an hiPSC tri-culture model of HIV infection","volume":"14","author":"Ryan","year":"2020","journal-title":"Stem Cell Reports"},{"issue":"Suppl. 2","key":"10.1016\/j.vascn.2022.107157_bb0415","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/13550280290101094","article-title":"The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/j.vascn.2022.107157_bb0420","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","article-title":"HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990\u20131998","volume":"56","author":"Sacktor","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0425","article-title":"Cross-sectional and cumulative longitudinal central nervous system penetration effectiveness scores are not associated with neurocognitive impairment in a well treated aging human immunodeficiency virus-positive population in Switzerland","volume":"6","author":"Santos","year":"2019","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.vascn.2022.107157_bb0430","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","article-title":"HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0435","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/13550280591002342","article-title":"Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors","volume":"11","author":"Schweinsburg","year":"2005","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/j.vascn.2022.107157_bb0440","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.031906","article-title":"High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell-derived neurons","volume":"11","author":"Sherman","year":"2018","journal-title":"Disease Models & Mechanisms"},{"key":"10.1016\/j.vascn.2022.107157_bb0445","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s10461-014-0747-6","article-title":"A systematic review of psychological functioning of children exposed to HIV: Using evidence to plan for tomorrow\u2019s HIV needs","volume":"18","author":"Sherr","year":"2014","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.vascn.2022.107157_bb0450","doi-asserted-by":"crossref","first-page":"10495","DOI":"10.1038\/s41598-019-46930-1","article-title":"Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy","volume":"9","author":"Shiau","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2022.107157_bb0455","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-153-7-201010050-00008","article-title":"Age at cancer diagnosis among persons with AIDS in the United States","volume":"153","author":"Shiels","year":"2010","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.vascn.2022.107157_bb0460","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007096","article-title":"HIV latency","volume":"1","author":"Siliciano","year":"2011","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.vascn.2022.107157_bb0465","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-63849-6.00007-4","article-title":"HIV-associated neurocognitive disorder","volume":"152","author":"Smail","year":"2018","journal-title":"Handbook of Clinical Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0470","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/meth.1999.0774","article-title":"Detecting action potentials in neuronal populations with calcium imaging","volume":"18","author":"Smetters","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.vascn.2022.107157_bb0475","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11481-017-9761-6","article-title":"Differential effects of antiretroviral drugs on neurons in vitro: Roles for oxidative stress and integrated stress response","volume":"13","author":"Stern","year":"2018","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.vascn.2022.107157_bb0480","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1126\/science.1081412","article-title":"Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor","volume":"299","author":"Straight","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vascn.2022.107157_bb0485","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/QAI.0b013e3181af83d6","article-title":"Changes in cognition during antiretroviral therapy: Comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders","volume":"52","author":"Tozzi","year":"2009","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.vascn.2022.107157_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1468-1331.2010.03291.x","article-title":"HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era","volume":"18","author":"UK Collaborative HIV Cohort (CHIC) Study Steering Committee","year":"2011","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.vascn.2022.107157_bb0490","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/QAD.0000000000000538","article-title":"Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?","volume":"29","author":"Underwood","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.vascn.2022.107157_bb0495","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fncel.2014.00396","article-title":"Neurogenesis in the embryonic and adult brain: Same regulators, different roles","volume":"8","author":"Urban","year":"2014","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.vascn.2022.107157_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224930","article-title":"Lower IQ and poorer cognitive profiles in treated perinatally HIV-infected children is irrespective of having a background of international adoption","volume":"14","author":"Van den Hof","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2022.107157_bb0505","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semcdb.2018.12.006","article-title":"Decoding epigenetic cell signaling in neuronal differentiation","volume":"95","author":"Vieira","year":"2019","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"10.1016\/j.vascn.2022.107157_bb0510","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1177\/1535370218801309","article-title":"Drug discovery and development: Biomarkers of neurotoxicity and neurodegeneration","volume":"243","author":"Walker","year":"2018","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"key":"10.1016\/j.vascn.2022.107157_bb0515","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","article-title":"Microglial cells: The main HIV-1 reservoir in the brain","volume":"9","author":"Wallet","year":"2019","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10.1016\/j.vascn.2022.107157_bb0520","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/toxsci\/kfy270","article-title":"Today\u2019s challenges to De-risk and predict drug safety in human \u201cMind-the-Gap\u201d","volume":"167","author":"Weaver","year":"2019","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2022.107157_bb0525","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ceca.2018.07.001","article-title":"Neuronal calcium signaling via store-operated channels in health and disease","volume":"74","author":"Wegierski","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.vascn.2022.107157_bb0530","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11481-008-9136-0","article-title":"The comorbidity of HIV-associated neurocognitive disorders and Alzheimer\u2019s disease: A foreseeable medical challenge in post-HAART era","volume":"4","author":"Xu","year":"2009","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.vascn.2022.107157_bb0535","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s11481-017-9755-4","article-title":"Combined medication of antiretroviral drugs tenofovir disoproxil fumarate, emtricitabine, and raltegravir reduces neural progenitor cell proliferation in vivo and in vitro","volume":"12","author":"Xu","year":"2017","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.vascn.2022.107157_bb0540","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.23571","article-title":"Neuroinflammation in the central nervous system: Symphony of glial cells","volume":"67","author":"Yang","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.vascn.2022.107157_bb0545","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrn.2016.70","article-title":"Epigenetic mechanisms in neurogenesis","volume":"17","author":"Yao","year":"2016","journal-title":"Nature Reviews. Neuroscience"},{"issue":"1","key":"10.1016\/j.vascn.2022.107157_bb0550","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11481-019-09868-9","article-title":"Beneficial and adverse effects of cART affect neurocognitive function in HIV-1 infection: Balancing viral suppression against neuronal stress and injury","volume":"16","author":"Yuan","year":"2021","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.vascn.2022.107157_bb0555","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"Journal of Biomolecular Screening"},{"key":"10.1016\/j.vascn.2022.107157_bb0560","article-title":"Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:05:21Z","timestamp":1761005121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871922000041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":111,"alternative-id":["S1056871922000041"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107157","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-content analysis and Kinetic Image Cytometry identify toxicity and epigenetic effects of HIV antiretrovirals on human iPSC-neurons and primary neural precursor cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107157"}}